Close
Smart Skin Technologies
Thermofisher
Production & Manufacturing

Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Production & Manufacturing

Bilayer Tablets Supporting Combination Drug Delivery

The pharmaceutical industry has increasingly turned toward fixed-dose combinations...
Production & Manufacturing

Multiparticulate Capsules Enhancing Oral Dose Delivery

The development of oral solid dosage forms has evolved...
Production & Manufacturing

HPMC Capsules Supporting Flexible Oral Drug Formulation

The pharmaceutical industry has seen a clear shift toward...
- Advertisement -
Xylem

Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.

Earlier, the company has received a warning letter from the agency on 25 August 2010 for violating good manufacturing practice regulations. The issuance of the letter follows FDA inspection of the site.

Caraco, now wholly owned by Sun Pharma, continues to work with consultants to resolve the issues raised by the FDA at its Detroit plant.

Xylem

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
Download the Media Pack to activate your presence across the global pharma and life sciences ecosystem.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Previous article
MHRA approves Ajanta Pharma Paithan manufacturing plant
Next article
CMC Biologics, Inspiration team up to manufacture hemophilia B drug

Related stories

Production & Manufacturing

Bilayer Tablets Supporting Combination Drug Delivery

The pharmaceutical industry has increasingly turned toward fixed-dose combinations...
Production & Manufacturing

Multiparticulate Capsules Enhancing Oral Dose Delivery

The development of oral solid dosage forms has evolved...
Production & Manufacturing

HPMC Capsules Supporting Flexible Oral Drug Formulation

The pharmaceutical industry has seen a clear shift toward...
Production & Manufacturing

Wet Granulation Strategies Improving Oral Solid Dose Uniformity

In the production of oral solid dosage forms, achieving...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
CPHI & PMEC Shenzhen 2026

CPHI & PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand...

AI in Drug Discovery

Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery